"Our basic drugs in the service of humanity worldwide"
Company
About Company
Mission & Vision
Quality Policy
Leadership
Plant & Facilities
Products
APIs
Drug Intermediates
Fine Chemicals
R&D
Contract Manufacturing
Investors
Shareholder Information
Corporate Governance
Financial Information
General Meetings
Regulation 46
Careers
Company
About Company
Mission & Vision
Quality Policy
Leadership
Plant & Facilities
Products
APIs
Drug Intermediates
Fine Chemicals
R&D
Contract Manufacturing
Investors
Shareholder Information
Corporate Governance
Financial Information
General Meetings
Regulation 46
Careers
Contact Us
Annual Report
Home
»
Annual Report
Shareholder Information
Corporate Information
Shareholding pattern
RTA details
KYC Forms for Shareholders
Corporate Governance
Corporate Updates
Policies
Board & Committee Composition
Financial Information
Financial Results
Board Meeting Intimation
Board Meeting Outcome
General Meetings
Annual Report
Annual Return
Voting Results
AGM/EGM proceedings
AGM/EGM Notice
Regulation 46
Regulation 46
Select Year
F.Y. 2024-25
F.Y. 2023-24
F.Y. 2022-23
F.Y. 2021-22
F.Y. 2020-21
F.Y. 2019-20
F.Y. 2018-19
F.Y. 2017-18
F.Y. 2016-17
F.Y. 2015-16
F.Y. 2014-15
F.Y. 2013-14
F.Y. 2024-25
Annual Report
F.Y. 2023-24
Annual Report
F.Y. 2022-23
Annual Report
F.Y. 2021-22
Annual Report
F.Y. 2020-21
Annual Report
F.Y. 2019-20
Annual Report
F.Y. 2018-19
Annual Report
F.Y. 2017-18
Annual Report
F.Y. 2016-17
Annual Report
F.Y. 2015-16
Annual Report
F.Y. 2014-15
Annual Report
F.Y. 2013-14
Annual Report
